HORIZON-EIC-2026-PATHFINDERCHALLENGES-01-02: Biotechnology for healthy ageing

Listed on GrantGunner. Last checked 3 Oct 2026.

About this grant

The call encourages the development of clinically validated interventions targeting the root cause of multiple age-related diseases and enabling personalized care based on molecular phenotyping. EUR 96,000,000 is available, with funding expected for up to 8 projects with an EU contribution between EUR 500,000 and EUR 4,000,000 per project. Consortia of research organizations, biotechnology and pharmaceutical companies from EU member states and Horizon Europe associated countries may apply.

Who can apply

Consortia of research organizations, biotech and pharmaceutical companies from EU member states and Horizon Europe associated countries may apply. Access to appropriate validation cohorts is required.

Browse all open grants

More grants from Evropska komisija